A study of CD4 count and cervical epithelial abnormality in HIV positive women
Abstract
Introduction: Cervical epithelial cell abnormalities (ECA) can result in cervical cancer which is the most common cause of cancer related death especially in developing countries. The aim of the present study is to find the association of CD4 count and Cervical epithelial abnormality in HIV positive women.
Materials and Methods: A study of association between cervical epithelial abnormality and CD4 count in HIV positive women was taken up in a Care and Support Hospital in collaboration with the Department of Pathology, Government Medical College, Ananthapuramu. Based on the observations, periodic cervical screening in HIV positive women is emphasized.
Results: 3.03% of women showed presence of cervical epithelial abnormality among HIV positive women. More number of HSIL (50%) followed by LSIL (28.2%), ASCUS (20.16%) and Carcinoma Cervix (1.6%).
Conclusion: Present study also emphasizes that patients with low CD4 count are at high risk of developing precancerous lesions of cervix. Hence periodic biannual cervical screening is required for HIV positive women whose CD4 count is below 200, to bring down the incidence of cervical malignancy and premalignant conditions.
Downloads
References
Available at http://www.who.net
Melkamu Getinet, Baye Gelaw, Abinet Sisay, Eiman A Mahmoud and Abate Assefa. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015; 15: 16.doi: https://doi.org/10.1186/s12907-015-0016-2.
Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine.2006;24(1):S1–15.doi: https://doi.org/10.1016/j.vaccine.2005.09.054.
Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, et al. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol. 2008;46:1060–6.doi: https://doi.org/10.1128/jcm.02202-07.
Luyten A, Buttmann-Schweiger N, Luyten K, Mauritz C, Reinecke-Lüthge A, Pietralla M, et al. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in locally organized screening programs. Int J Cancer. 2014;135:1408–16.doi: https://doi.org/10.1002/ijc.28783.
Hailu A, Mariam DH. Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study. BMC Cancer. 2013;13:69.doi: https://doi.org/10.1186/1471-2407-13-69.
Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull. 2007;85(9):719–26.doi: https://doi.org/10.2471/blt.06.038414.
Kerr DJ, Fiander AN. Towards Prevention of Cervical Cancer in Africa. 2009. Available at http://www.afrox.org. Accessed on Dec 15, 2013.
Kravchenko J, Akushevich I, Sudenga SL, Wilson CM, Levitan EB. ShresthaS: Transitional probability-based model for HPV clearance in HIV-1-positiveadolescent females. PLoS One. 2012;7:e30736.doi: https://doi.org/10.1371/journal.pone.0030736.
Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a North American multi-cohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013;62:405–13.doi: https://doi.org/10.1097/qai.0b013e31828177d7.
Terry R. Management of patients with atypical squamous cells of undetermined significance (ASCUS) on Papanicolaou smears. J Am Osteopath Assoc. 1996;96(8):465–8.https://jaoa.org/article.aspx?articleid=2099148.
Shruti Kalra – studies examine relation between HIV and cervical cancer in women. The AIDS Beacon, July 23 - 2010.
Brunih, Baerionuevo, Rosas L et al. ICO information center on HPV and Cancer. Human Papilloma Virus and related diseases in India, Summary report. 2015;12-23.
Annual report 2013-14, New Delhi. Department of AIDS control, National AIDS Control Organization; Ministry of Health and Family Welfare; Government of India, 2014.http://naco.gov.in/sites/default/files/NACO_English%202013-14.pdf.
Sarkar K, Pal R, Bal B, et al., Oncogenic HPV among HIV infected female population in West Bengal, India; BMC –Infectious diseases. 2011; 11:72.doi: https://doi.org/10.1186/1471-2334-11-72.
Aggarwal R, Sachdeva RK, et al., HPV genotyping in North Indian women infected with HIV. International Journal of Gynecology and Patholody 2012; 31: 475-81.doi: https://doi.org/10.1097/pgp.0b013e31824a1d60.
Issakidis P, Dimple S. Verghese et al., HPV infection, cervical abnormalities and cancer in HIV infected women in Mumbai India – 12 month follow up. International Journal of Women’s Health 2013; 5: 487-94.doi: https://dx.doi.org/10.2147%2FIJWH.S47710.
Wright TC, Jr Schiffman M: Adding a test for human HPV DNA to cervical screening; New English Journal of Medicine 2003; 348: 489-90.doi: https://doi.org/10.1056/nejmp020178.
Chakravarty J, Chourasia A, Thakur M, Singh AK, Sundar S, Agrawal NR. Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India. Indian J Med Res [serial online] 2016 [cited 2020 Feb 12];143:79-86. Available from: http://www.ijmr.org.in/text.asp?2016/143/1/79/178614.
Mangdaviraj, Kerr SJ et al., MAsir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV positive women in resource limited setting. International Journal of STD and AIDS. 2008; 19: 529-32.doi: https://doi.org/10.1258%2Fijsa.2007.007222.
Massad LS, Ahdieh. L, Benning et al., Evolution of cervical abnormatlities among women with HIV-I, evidence from surveillance cytology in the women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndrome. 2001; 27: 432-42.doi: https://doi.org/10.1097/00126334-200108150-00003.
OAI - Open Archives Initiative
